Abstract:BACKGROUND:Gastric cancer (GC) is common and its prognosis is often poor due to difficulties in early diagnosis and optimal treatment strategies. TNM staging system is useful in predicting prognosis but only possible after surgery. Therefore, it is desirable to investigate prognostic factors/markers that may predict prognosis before surgery by which helps appropriate management decisions preoperatively.METHODS:A total of 320 GC patients were consecutively recruited from 2004 to 2013 and followed up for 127 months (10.6 years) after surgery. These patients' were examined for body mass index (BMI) and blood levels of albumin, triglyceride, total cholesterol, low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C). Kaplan-Meier method and log rank test were used to analyze long-term survival using the above potential risk markers. We first employed medians of these variables to reveal maximal potentials of the above prognostic predictors.RESULTS:Three major findings were obtained: (1) Preoperative BMI was positively correlated with albumin (r = 0.144, P<0.05) and triglyceride (r = 0.365, P<0.01), but negatively correlated with TNM staging (r = -0.265, P<0.05). Preoperative albumin levels were positively correlated with triglyceride (r = 0.173, P<0.05) but again, negatively correlated with TNM staging (r = -0.137, P<0.05); (2) Poor survival was observed in GC patients with lower levels of BMI (P = 0.028), albumin (P = 0.004), and triglyceride (P = 0.043), respectively. Receiver operating characteristic (ROC) curve analyses suggested BMI, albumin and triglyceride to have survival-predictor powers similar to TNM system; and (3) Cox multi-factorial analyses demonstrated that age (P = 0.049), BMI (P = 0.016), cell differentiation (P = 0.001), and TNM staging (P = 0.011) were independent overall survival-predictors for GC patients.CONCLUSIONS:Preoperative BMI, albumin, and triglyceride levels are capable of predicting survival for GC patients superior to postoperative TNM system in terms of timing for management. As potential survival-predictors, preoperative tests of BMI, albumin and triglyceride, combined with clinical imaging, may help personalized management for GC patients including planning surgical strategy, optimal radio-chemotherapy and appropriate follow-up intervals after surgery.

Changes of Blood Lipid Metabolism in Elderly Patients with Advanced Gastric Cancer and Its Clinical Significance

New Utility of an Old Marker: Serum Low-Density Lipoprotein Predicts Histopathological Response of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.

Adverse Effects of Low Serum Lipoprotein Cholesterol on the Immune Microenvironment in Gastric Cancer: a Case‒control Study

Tumor and Serum Gamma-Glutamyl Transpeptidase, New Prognostic and Molecular Interpretation of an Old Biomarker in Gastric Cancer

Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival

Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis

Lipid levels and insulin resistance markers in gastric cancer patients: diagnostic and prognostic significance

Predictive Role of Serum Cholesterol and Triglycerides in Cervical Cancer Survival.

Triglyceride-to-high density lipoprotein cholesterol ratio predicts clinical outcomes in patients with gastric cancer.

Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer.

Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer

Clinical significance of serum tumor marker for advanced gastric cancer with palliative chemotherapy: A retrospective study.

Changes of Lipid and Lipoprotein in Liver Cancer

Study on Chemotherapy-induced Disorders of Lipid Metabolism in Patients with Gynecologic Malignant Tumor

Changes and clinical significance of serum soluble human leukocyte antigen-G and growth differentiation factor 15 in gastric cancer

Association of Serum Lipid Levels and Clinical Outcomes in Early Breast Cancer Patients

Lipid metabolism abnormalities in patients with colorectal cancer: distribution characteristics and clinical value

Dyslipidemia in Chinese Pancreatic Cancer Patients: A Two-Center Retrospective Study

Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection

Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.

Predictive Value of a Reduction in the Level of High-Density Lipoprotein-Cholesterol in Patients with Non-Small-cell Lung Cancer Undergoing Radical Resection and Adjuvant Chemotherapy: a Retrospective Observational Study